Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Hemolytic Uremic Syndrome (HUS) | Urology & Nephrology